<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF66505C-CECD-4483-8FDA-E8347F32AF9E"><gtr:id>FF66505C-CECD-4483-8FDA-E8347F32AF9E</gtr:id><gtr:name>King's College Hospital Charity</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B6161E56-8D19-4789-830F-1528216FD2B6"><gtr:id>B6161E56-8D19-4789-830F-1528216FD2B6</gtr:id><gtr:name>MRC Biostatistics Unit</gtr:name><gtr:address><gtr:line1>Institute of Public Health</gtr:line1><gtr:line2>University Fovie Site</gtr:line2><gtr:line3>Robinson Way</gtr:line3><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2SR</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6161E56-8D19-4789-830F-1528216FD2B6"><gtr:id>B6161E56-8D19-4789-830F-1528216FD2B6</gtr:id><gtr:name>MRC Biostatistics Unit</gtr:name><gtr:address><gtr:line1>Institute of Public Health</gtr:line1><gtr:line2>University Fovie Site</gtr:line2><gtr:line3>Robinson Way</gtr:line3><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2SR</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF66505C-CECD-4483-8FDA-E8347F32AF9E"><gtr:id>FF66505C-CECD-4483-8FDA-E8347F32AF9E</gtr:id><gtr:name>King's College Hospital Charity</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4C862B58-35BC-4A9F-A962-4FCC64A29BE1"><gtr:id>4C862B58-35BC-4A9F-A962-4FCC64A29BE1</gtr:id><gtr:name>MRC Dementias Platform UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/01882632-1970-4184-993E-B00468A3E9E0"><gtr:id>01882632-1970-4184-993E-B00468A3E9E0</gtr:id><gtr:firstName>Brian</gtr:firstName><gtr:surname>Tom</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1302%2F3"><gtr:id>351307B4-FE92-4B4D-9221-A7DD5F9E227F</gtr:id><gtr:title>Statistics for Stratified Medicine and Analysis of Complex Phenotypes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1302/3</gtr:grantReference><gtr:abstractText>Many diseases and conditions, such as cancers, dementia and rheumatic disorders, are multi-factorial; exhibiting a range of biological manifestations that reflect the contribution of genetic and environmental factors. Even across individuals with rare diseases, which may result from single gene mutations, varying symptoms, health outcomes and treatment responses are seen. The complexity of diseases leads to many challenges ranging from understanding disease mechanisms and susceptibility to risk prediction and development and application of treatments. Stratified medicine, where &amp;quot;homogeneous&amp;quot; groups of people likely to respond similarly to treatment or have similar underlying disease mechanism or risk are sought based on biomarker information, is aimed at targeting therapies and optimal decision making for groups of patients who have shared biological characteristics. That genetic, molecular and imaging technologies have transformed biology has meant the need for those trained in analysing complex data, accounting for uncertainty and making evidence-based conclusions is paramount. Our programme will address statistical issues arising from using complex biological and clinical data for further understanding of diseases and to develop models aimed at risk prediction, stratified prevention, projection of disease course, treatment response, safety and the likelihood of adverse events and the tailoring of therapeutics to individuals.</gtr:abstractText><gtr:technicalSummary>Stratified Medicine is a strategic priority for the MRC (and other organisations), and a substantial programme of investment by the MRC has begun and will continue for the coming years. The stratified medicine paradigm acknowledges the enormous biotechnological advances in generating and collecting detailed biological genotypic and phenotypic information across the various levels of organisation of the (human) biological system with the capacity to match the complexity of diseases and unmask patterns which can identify new and more subtle strata of disease. The unprecedented availability and progress of ?omics? technologies for characterizing individual DNA mutations, metabolic profiles, protein expression and localisation, mRNA expression and epigenetic signatures in specific cell types, coupled with imaging and more traditional clinical, lifestyle and environmental data, have presented opportunities for further understanding of mechanisms, outcomes and molecular heterogeneity of diseases. This paves the way for individual-level models aimed at risk assessment and stratified prevention, projection of disease course, treatment response, safety and the likelihood of adverse events. 

We will undertake a programme of statistical methodological research that encompasses risk stratification, prediction and validation, integrative and joint modelling of molecular and clinical data of various kinds and complexities (and their conversion into meaningful outputs that can inform health care decisions), mechanistic understanding and causality, treatment strategies and the design of innovative/purposeful clinical trials for biomarkers, rare diseases and dynamic treatment regimes. Both Bayesian and non-Bayesian methodology will be developed. 

We are research partners in a number of MRC and other funded consortia in stratified medicine, and have close links with teams in North America, Europe and the UK. Our collaborations cover many diseases, medical conditions and areas. For example, we are involved in projects in rheumatology, dementia, rare diseases, HIV, antibiotic resistance and blood donation. Some of the goals of these projects are shared. We therefore envisage that methodology developed may be transferrable across diseases and medical areas, although tailoring may be required.</gtr:technicalSummary><gtr:fund><gtr:end>2016-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>522949</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>D&amp;amp;FP</gtr:description><gtr:id>800A48E8-C674-41EC-A50D-834D854B67A0</gtr:id><gtr:impact>None at present. Collaboration is multi-disciplinary; Psychiatrists, Clinicians, Statisticians, Bioinformaticians, Industry</gtr:impact><gtr:outcomeId>58c6833db9e4a5.49551186-1</gtr:outcomeId><gtr:partnerContribution>Co-investigators on this MRC award</gtr:partnerContribution><gtr:piContribution>Statistical Lead</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medical and Human Sciences</gtr:department><gtr:description>MASTERPLANS</gtr:description><gtr:id>155CA4E6-BF9F-428A-B0EA-2B24AF5137AA</gtr:id><gtr:impact>Collaboration is multi-disciplinary bringing together industry and academic experts, covering basic, clinical, therapeutic development and biostatistical research, in this lupus stratified medicine consortium</gtr:impact><gtr:outcomeId>56e15199b0e118.88827775-1</gtr:outcomeId><gtr:partnerContribution>Principal Investigator</gtr:partnerContribution><gtr:piContribution>Co-applicants who are providing the statistical expertise to this MRC stratified medicine initiative in systemic lupus erythematosus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Dementias Platform UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DPUK</gtr:description><gtr:id>D33D92E0-5368-4C7B-81E6-425B7216B1E7</gtr:id><gtr:impact>Multi-disciplinary - academia, industry and clinicians</gtr:impact><gtr:outcomeId>56e16127bb7ca7.14121872-1</gtr:outcomeId><gtr:partnerContribution>Funding</gtr:partnerContribution><gtr:piContribution>Lead Work Package 14B - Statistics</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>GAUCHERITE</gtr:description><gtr:id>273764DD-2A1F-4A25-947E-B6596955F4A7</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>5463ae4236aa95.45955241-1</gtr:outcomeId><gtr:partnerContribution>Principal Investigators</gtr:partnerContribution><gtr:piContribution>Co-applicant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Newcastle University Medical School</gtr:department><gtr:description>RA-MAP Consortium</gtr:description><gtr:id>D0282568-65C4-4664-BDF5-7A5D10979D32</gtr:id><gtr:impact>Inventory of Trials Workshop in Manchester</gtr:impact><gtr:outcomeId>5463a498e351e8.55463098-1</gtr:outcomeId><gtr:partnerContribution>Principal Investigators in the MRC/ABPI Immunology and Inflammation Initiative for Inflammatory Joint Disease</gtr:partnerContribution><gtr:piContribution>Co-applicant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>RA-MAP Consortium</gtr:description><gtr:id>3EC887A9-F819-42C8-8936-985364AAB407</gtr:id><gtr:impact>Inventory of Trials Workshop in Manchester</gtr:impact><gtr:outcomeId>5463a498e351e8.55463098-2</gtr:outcomeId><gtr:partnerContribution>Principal Investigators in the MRC/ABPI Immunology and Inflammation Initiative for Inflammatory Joint Disease</gtr:partnerContribution><gtr:piContribution>Co-applicant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>EPAD</gtr:description><gtr:id>4A3287DB-4620-47C1-8F5F-3903F1202E89</gtr:id><gtr:impact>Multi-disciplinary: Clinical, Industrial, Statistical</gtr:impact><gtr:outcomeId>56e1600069b907.98046992-1</gtr:outcomeId><gtr:partnerContribution>Funding</gtr:partnerContribution><gtr:piContribution>Statistical Lead in the Disease Modelling of WP2</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GAUCHERITE</gtr:description><gtr:id>98E2211C-914F-4A2E-9D6A-0618A8D5B7ED</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>5463ae4236aa95.45955241-2</gtr:outcomeId><gtr:partnerContribution>Principal Investigators</gtr:partnerContribution><gtr:piContribution>Co-applicant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital Charity</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIHR TITRATE</gtr:description><gtr:id>85E071FE-7C62-4D8C-B221-32BC671F72FE</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>5463ac2d033904.90139090-1</gtr:outcomeId><gtr:partnerContribution>Principal Investigator on NIHR Programme Grant</gtr:partnerContribution><gtr:piContribution>Co-applicant</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ADVANCED MUSCULOSKELETAL SUMMER SCHOOL</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7BEF97CE-3A34-4FDA-BBDA-D1FC08D474DA</gtr:id><gtr:impact>Taught on the Advanced Musculoskeletal Summer School in Manchester on the 5th July 2016. Delivered the Survival Analysis and Multi-state Models module. This was attended by clinicians, allied health professionals, and researchers working in musculoskeletal research</gtr:impact><gtr:outcomeId>58c6892d33e268.55139613</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EPAD General Assembly Talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A479420-E529-4BE5-95CC-B274ACACA97E</gtr:id><gtr:impact>Update Talk on the Disease Modelling work done in WP2.</gtr:impact><gtr:outcomeId>58c68bcc2cb015.13098457</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6DD33AC4-0AC2-4B48-B896-5625B1A5C4E1</gtr:id><gtr:impact>Each year BSU participate in Cambridge Science Festival - members of the general public explore and discuss issues of scientific interest and concern, through a series of different events. The festival also aims to raise aspirations by encouraging young people to consider a career in science, technology, engineering or mathematics.

BSU take part over two full days - 'Science Saturday' and the 'Cambridge Biomedical Campus' day. The unit presents a stand with 4 - 5 interactive activities that each communicate a basic statistical method or idea, representing one of the four research themes in the unit. Each year a new activity is developed and delivered requiring scientific input from staff and students across the unit. Over the two days, BSU engage with approximately 500 adults and children who visit the festival.</gtr:impact><gtr:outcomeId>56ddaf09a1d6d4.78689050</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media enquiry - BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>19F50158-DAFA-46DB-9391-06281EFAE35F</gtr:id><gtr:impact>Article in BBC News (http://www.bbc.co.uk/news/health-37131836) and feature on BBC Radio 4 about new research to help spot early signs of Alzheimer's - based on published research co-authored by Brian Tom, Programme Leader Track http://www.mrc.ac.uk/news/browse/world-s-most-in-depth-study-to-detect-early-signs-of-alzheimer-s-disease/</gtr:impact><gtr:outcomeId>58af02d3a840c3.39011439</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Toronto PsA Meeting Talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>39F53FD7-6A51-4438-8E9D-D3CD0420F113</gtr:id><gtr:impact>Gave a talk at the Scientific Meeting of the University of Toronto Psoriatic Arthritis Clinic. The attendees were clinicians, researchers, patient group members, funders and Industry.</gtr:impact><gtr:outcomeId>58c68afd227fb5.34352136</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Armitage Lectures</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6235D7C5-A00F-4775-93BC-7EAECE38B887</gtr:id><gtr:impact>Annual workshop and lecture created and hosted by the MRC Biostatistics Unit, to honour the immense contributions of Professor Peter Armitage who was at the unit from 1947 to 1961, and whose work is recognised throughout the world as achieving a successful balance between methodological rigour and applied commonsense, to which all statisticians aspire. An eminent medical statistician visits for a week and works with members of the unit. The highlight is the Armitage Lecture, where more than 100 delegates attend. This event raises the unit research profile and creates new collaborations. 

Brian Tom was the scientific lead for the 2016 event - identifying a suitable Armitage speaker, and providing scientific oversight across all matters relating to the event.</gtr:impact><gtr:outcomeId>58b6f94a3e8fe1.94120087</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.mrc-bsu.cam.ac.uk/news-and-events/armitage-lectureships-and-workshops/</gtr:url><gtr:year>2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BSU Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6B0065BA-7063-4778-90D3-C277949CA48F</gtr:id><gtr:impact>Unit held open day as part of MRC Festival of Medical Research. 

The aim of the open day was to welcome secondary school students and members of the general public to come to the unit, find out about the research the unit does, and to take part in activities that illustrate BSU research, with the overall theme being 'Fun with statistics'. An open day of this format was a first for the unit and overall it was a very successful event. There were 40 attendees over a 4 hour event. All attendees pre-booked and were split into 4 groups for a 1 hour session comprising of an introduction, participation in hands-on activities, and a brief careers talk. The small groups and length of session allowed for quality engagement between the scientists and the audience. 

Feedback from the attendees was very positive, and the wider MRC Festival activities that took place in Cambridge demonstrated the benefits in delivering these types of events.</gtr:impact><gtr:outcomeId>58aedd36b6e496.20351874</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.mrc-bsu.cam.ac.uk/bsu-open-day-2016-why-are-statistics-important/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Berkeley Talk</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5FB028D3-B0D6-442C-A7F6-29DF5B024FB4</gtr:id><gtr:impact>Gave a talk at a Global Alliance Meeting in Precision Medicine held at University of California Berkeley. Attendees were from the National University of Singapore, University of Cambridge, University of California San Francisco and University of California Berkeley</gtr:impact><gtr:outcomeId>58c68a18123a78.37416600</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>390000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>EPAD</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D48DCCE8-D976-4D6B-A767-88621C1C0E6C</gtr:id><gtr:outcomeId>56e158e213b929.28064981</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DPUK</gtr:description><gtr:fundingOrg>MRC Dementias Platform UK</gtr:fundingOrg><gtr:id>CF53A08C-9E5F-4F1B-A6E4-F24C24CF0AD7</gtr:id><gtr:outcomeId>56e15a29949319.36562210</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61882</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RA-MAP Consortium</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8B072DCA-B71A-41F9-A1CD-C5DF0BF5F1E2</gtr:id><gtr:outcomeId>56e157528f37f8.08463891</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60915</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Stratified Medicine</gtr:department><gtr:description>GAUCHERITE</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FE9E84EF-4CAE-4B65-B697-A7783FED36CE</gtr:id><gtr:outcomeId>56e15809492fc8.57068958</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>122542</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HOD</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>47C7BBC3-D236-45FB-B036-01B087B43990</gtr:id><gtr:outcomeId>56e15d2b946214.02923176</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>164800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Stratified Medicine</gtr:department><gtr:description>MASTERPLANS</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>165B7F9A-657D-4677-9662-D6DE85C5E1DA</gtr:id><gtr:outcomeId>56e15e18a53656.80680175</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>NIHR TITRATE</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>RP-PG-0610-10066</gtr:fundingRef><gtr:id>E6FFE034-DC5A-4EB1-8572-137AB4CBFFAC</gtr:id><gtr:outcomeId>56e15b9198dd74.74045701</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>44452</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>D&amp;amp;FP, Oxford- Lovestone</gtr:description><gtr:end>2020-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>43D56FF8-8BCF-4154-904E-40A6A895A6C4</gtr:id><gtr:outcomeId>58c13509d74034.16375999</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1BB93506-5E09-4EE6-90EA-5F498F2E2363</gtr:id><gtr:title>Second-Order Estimating Equations for Clustered Current Status Data from Family Studies Using Response-Dependent Sampling</gtr:title><gtr:parentPublicationTitle>Statistics in Biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bb0deeeec4bee40b70824ee22d01400"><gtr:id>0bb0deeeec4bee40b70824ee22d01400</gtr:id><gtr:otherNames>Zhong Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd57f87cd78.57431244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1F53708-78CD-4A19-A85D-FA0F89D175E8</gtr:id><gtr:title>Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e42e2c60de556d09e0b539c57888007"><gtr:id>9e42e2c60de556d09e0b539c57888007</gtr:id><gtr:otherNames>St?dler N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>5a31df8f49aed6.24056083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0CD90EF-1245-4F4E-A5E7-C818A3E2208D</gtr:id><gtr:title>A Gibbs Sampler for Learning DAGs.</gtr:title><gtr:parentPublicationTitle>Journal of machine learning research : JMLR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1494d5ea6a7574d503184999d781dbd5"><gtr:id>1494d5ea6a7574d503184999d781dbd5</gtr:id><gtr:otherNames>Goudie RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1532-4435</gtr:issn><gtr:outcomeId>5a3249049b24c8.43569123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>467465F7-9008-48B2-BF81-31F10DD38845</gtr:id><gtr:title>Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/287507cf26275f91e2ab1b48dbc45360"><gtr:id>287507cf26275f91e2ab1b48dbc45360</gtr:id><gtr:otherNames>Martin NH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5aa137165515c7.74010575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8A4E7C5-27DA-4DBF-9AC5-5AF1B47CC1AD</gtr:id><gtr:title>Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2).</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3a1304574d52ac06eb6caa30678dd01"><gtr:id>e3a1304574d52ac06eb6caa30678dd01</gtr:id><gtr:otherNames>Tom BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn><gtr:outcomeId>5675e1b5a40ef</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>114ED346-7775-4C1E-B97F-D4BE453E0B44</gtr:id><gtr:title>Trivariate mover-stayer counting process models for investigating joint damage in psoriatic arthritis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0211653ce4ccd246c7f9731a5d75f574"><gtr:id>0211653ce4ccd246c7f9731a5d75f574</gtr:id><gtr:otherNames>Yiu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>58aafc618a7650.17852157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2D03AAB-C71A-4EA2-85A9-50720A591C5E</gtr:id><gtr:title>Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1494d5ea6a7574d503184999d781dbd5"><gtr:id>1494d5ea6a7574d503184999d781dbd5</gtr:id><gtr:otherNames>Goudie RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>56d70cf1581547.94011392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2155214-7475-48A2-801B-6AF8299B470E</gtr:id><gtr:title>The RA-MAP Consortium: a working model for academia-industry collaboration.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031b417a432339f3936997a58a69cd87"><gtr:id>031b417a432339f3936997a58a69cd87</gtr:id><gtr:otherNames>Cope AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1759-4790</gtr:issn><gtr:outcomeId>5aa137f93ece69.45058043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40433BEF-469D-4E7E-BD8E-F32677774439</gtr:id><gtr:title>Synthesising evidence to estimate pandemic (2009) A/H1N1 influenza severity in 2009-2011</gtr:title><gtr:parentPublicationTitle>The Annals of Applied Statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/502852ef581baaa93a9bf5be6553ef43"><gtr:id>502852ef581baaa93a9bf5be6553ef43</gtr:id><gtr:otherNames>Presanis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56d70cf216fb48.22095399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAC9C4F0-3786-403D-A503-6C7F86B72AB7</gtr:id><gtr:title>Two-Part and Related Regression Models for Longitudinal Data.</gtr:title><gtr:parentPublicationTitle>Annual review of statistics and its application</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01fc75982c6fe39270fec9a0d79e6f6"><gtr:id>c01fc75982c6fe39270fec9a0d79e6f6</gtr:id><gtr:otherNames>Farewell VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2326-8298</gtr:issn><gtr:outcomeId>58aafc62345719.31973160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8CCF7F8-E5E4-4BDF-8CD9-1EDEBEDE6B29</gtr:id><gtr:title>A likelihood-based two-part marginal model for longitudinal semicontinuous data.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16c121382f6709092a03a017793856f8"><gtr:id>16c121382f6709092a03a017793856f8</gtr:id><gtr:otherNames>Su L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>56d70cf246be89.16171923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6310C1-D33B-4E3D-816A-A37DE065F6F9</gtr:id><gtr:title>Multiple Imputation of Missing Composite Outcomes in Longitudinal Data.</gtr:title><gtr:parentPublicationTitle>Statistics in biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52ddff613c446ee81a80d3d69a3d495d"><gtr:id>52ddff613c446ee81a80d3d69a3d495d</gtr:id><gtr:otherNames>O'Keeffe AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1867-1764</gtr:issn><gtr:outcomeId>58aafc61d7c855.94346416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C72E24-1F61-41A2-B7B3-F4B09DA6A8C9</gtr:id><gtr:title>Exploring the existence of a stayer population with mover-stayer counting process models: application to joint damage in psoriatic arthritis.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society. Series C, Applied statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0211653ce4ccd246c7f9731a5d75f574"><gtr:id>0211653ce4ccd246c7f9731a5d75f574</gtr:id><gtr:otherNames>Yiu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0035-9254</gtr:issn><gtr:outcomeId>58aafc620e5648.36272667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EF5DE25-1335-4AAD-9CC1-CBED55950760</gtr:id><gtr:title>Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.</gtr:title><gtr:parentPublicationTitle>Cell systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/296d4a36479ecee4fdda99c41b272a33"><gtr:id>296d4a36479ecee4fdda99c41b272a33</gtr:id><gtr:otherNames>Hill SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2405-4712</gtr:issn><gtr:outcomeId>5a2fd4e24e1071.50661887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD377FD1-1E81-4107-8110-083145052BED</gtr:id><gtr:title>Happiness as a Driver of Risk-avoiding Behaviour: Theory and an Empirical Study of Seatbelt Wearing and Automobile Accidents</gtr:title><gtr:parentPublicationTitle>Economica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1195ac0da4eb04548aadc5acff690b66"><gtr:id>1195ac0da4eb04548aadc5acff690b66</gtr:id><gtr:otherNames>Goudie R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>56d70cf1af58a7.18815400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47A7222-162F-4A16-8BE4-C036615BF145</gtr:id><gtr:title>Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1494d5ea6a7574d503184999d781dbd5"><gtr:id>1494d5ea6a7574d503184999d781dbd5</gtr:id><gtr:otherNames>Goudie RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn><gtr:outcomeId>56d70cf1875525.57810740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>829772B8-8F7E-45E7-B806-A6EB3C4903DC</gtr:id><gtr:title>Two-part models with stochastic processes for modelling longitudinal semicontinuous data: Computationally efficient inference and modelling the overall marginal mean.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0211653ce4ccd246c7f9731a5d75f574"><gtr:id>0211653ce4ccd246c7f9731a5d75f574</gtr:id><gtr:otherNames>Yiu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>5a8d4ff68d32a5.78123547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA882D3-E86A-4080-BB8D-972BA4D4D955</gtr:id><gtr:title>A corrected formulation for marginal inference derived from two-part mixed models for longitudinal semi-continuous data.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3a1304574d52ac06eb6caa30678dd01"><gtr:id>e3a1304574d52ac06eb6caa30678dd01</gtr:id><gtr:otherNames>Tom BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>56d70cf26c1f39.88781505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C390DDE-F4BA-43FC-8CCD-2304949666F7</gtr:id><gtr:title>Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia (New York, N. Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d679dbb922b3259a9121cc6089b55e91"><gtr:id>d679dbb922b3259a9121cc6089b55e91</gtr:id><gtr:otherNames>Huang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2352-8737</gtr:issn><gtr:outcomeId>5a31d9f49ea1b7.92121610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C66F378-D473-4C6A-871A-74438894CACE</gtr:id><gtr:title>Maximum likelihood and pseudo score approaches for parametric time-to-event analysis with informative entry times</gtr:title><gtr:parentPublicationTitle>The Annals of Applied Statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/084da22f8b276f805e23655f513728b0"><gtr:id>084da22f8b276f805e23655f513728b0</gtr:id><gtr:otherNames>Tom B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545b710e327266.92447087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D811CB1F-B0CA-4E56-85FD-C0B492BDD9B3</gtr:id><gtr:title>Clustered multistate models with observation level random effects, mover-stayer effects and dynamic covariates: modelling transition intensities and sojourn times in a study of psoriatic arthritis.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society. Series C, Applied statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0211653ce4ccd246c7f9731a5d75f574"><gtr:id>0211653ce4ccd246c7f9731a5d75f574</gtr:id><gtr:otherNames>Yiu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0035-9254</gtr:issn><gtr:outcomeId>5a2fd57f203aa0.21938987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9F94CA6-4109-49B9-BD78-409EF897C612</gtr:id><gtr:title>A joint modelling approach for multistate processes subject to resolution and under intermittent observations.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0211653ce4ccd246c7f9731a5d75f574"><gtr:id>0211653ce4ccd246c7f9731a5d75f574</gtr:id><gtr:otherNames>Yiu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>58aafc61ada684.32048032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC8A6EE6-7FBF-49A0-B7DA-53A4082F8F49</gtr:id><gtr:title>A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c49755f7f5b167b37c218aa065bc555"><gtr:id>5c49755f7f5b167b37c218aa065bc555</gtr:id><gtr:otherNames>Ibrahim F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>58aafc625d6029.44293053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D288DA3-ED71-42EA-BD74-8A1FDCE73429</gtr:id><gtr:title>Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/031b417a432339f3936997a58a69cd87"><gtr:id>031b417a432339f3936997a58a69cd87</gtr:id><gtr:otherNames>Cope AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1759-4790</gtr:issn><gtr:outcomeId>5aa137f97be9e8.40480773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>788A0FB5-2819-48C3-BF29-BAEFD8AE34D0</gtr:id><gtr:title>The versatility of multi-state models for the analysis of longitudinal data with unobservable features.</gtr:title><gtr:parentPublicationTitle>Lifetime data analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01fc75982c6fe39270fec9a0d79e6f6"><gtr:id>c01fc75982c6fe39270fec9a0d79e6f6</gtr:id><gtr:otherNames>Farewell VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1380-7870</gtr:issn><gtr:outcomeId>545a74953f19b6.24604660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD4DF4EA-8883-4347-94BE-D801EE1A6D75</gtr:id><gtr:title>Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'</gtr:title><gtr:parentPublicationTitle>Statistical Communications in Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb8ab90d092ff34660700216fb79e846"><gtr:id>fb8ab90d092ff34660700216fb79e846</gtr:id><gtr:otherNames>Kassanjee R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c67f01db80e6.09680327</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1302/3</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>